Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Ocumension Therapeutics ( (HK:1477) ) has shared an announcement.
Ocumension Therapeutics has announced its upcoming annual general meeting scheduled for June 19, 2025, in Shanghai. The meeting will address several key resolutions, including the adoption of the company’s financial statements for 2024, the re-election of directors, and the reappointment of Deloitte Touche Tohmatsu as auditors. Additionally, the meeting will consider authorizing the board to issue additional shares, which could impact the company’s capital structure and market operations.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, focusing on the development and commercialization of ophthalmic therapies. The company operates within the healthcare industry, specifically targeting eye-related medical treatments.
YTD Price Performance: 22.67%
Average Trading Volume: 3,224,624
Technical Sentiment Signal: Hold
Current Market Cap: HK$4.53B
For an in-depth examination of 1477 stock, go to TipRanks’ Stock Analysis page.